Analysis of the immunomodulatory effects of Echinacea
investigations into the effects of supplementation with echinacea on parameters of the immune response in healthy adults
MediHerb Pty Ltd
20 participants
May 20, 2009
Interventional
Conditions
Summary
It is widely accepted that stimulation of the immune system is responsible for the perceived benefits of Echinacea. This study will examine the prophylactic use of echinacea on white cell counts, natural killer cell functionality, heat shock protein expression and echinacea pharmacokinetics.
Eligibility
Inclusion Criteria1
- Healthy individuals exhibiting no sign of respiratory illness in the 2 weeks before the trial commences.
Exclusion Criteria3
- Plant/pollen allery
- Lactation or pregnancy
- Diagnosed respiratory disease
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The tablets contain 675mg herb equivalent of Echinacea purpurea and 600mg herb equivalent of Echinacea angustifolia. Participants will take 2 tablets twice a day for 2 weeks
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12609000417280